|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.95 SAR | -0.11% |
|
-2.05% | -4.26% |
| 15/07 | JP Morgan Reduces Nahdi Medical's PT, Maintains Neutral Rating | MT |
| 04/06 | Morgan Stanley Lowers Nahdi Medical's PT, Keeps at Overweight | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 14.05x | 4.27x | 10.1x | 1.2x | 7.28x | 13.98x | 5.49% | 315.19Cr | ||
| 17.64x | 1.56x | 2.2x | 0.73x | 11.56x | 12.42x | -.--% | 1.53TCr | ||
| 22.91x | 2.54x | 3.82x | 0.9x | 15.95x | 16.21x | 0.99% | 692.88Cr | ||
| 16.23x | 1.7x | 1.87x | 0.73x | 7.56x | 9.53x | 2.3% | 599.17Cr | ||
| 13.57x | 2.04x | 0.84x | 0.87x | 6.26x | 8.2x | 3.16% | 384.28Cr | ||
| 14.77x | 2.77x | 0.71x | 0.62x | 4.89x | 8.08x | 4.68% | 323.79Cr | ||
| 15.52x | 7.02x | 2.37x | 0.94x | 7.03x | 9.76x | 4.16% | 322.79Cr | ||
| 39x | - | 1.24x | - | - | - | - | 253.09Cr | ||
| 23.15x | 4.05x | 1x | 0.66x | 8.51x | 13.93x | 1.77% | 170.45Cr | ||
| -89.86x | 2.95x | 1.51x | 0.47x | 17.51x | 105.89x | 0.01% | 156.31Cr | ||
| 45.31x | 4.98x | 1.07x | 1.32x | 15.25x | 29.2x | - | 100.75Cr | ||
| 13.11x | 2.33x | -0.8x | 0.85x | 7.04x | 14.05x | 5.62% | 94Cr | ||
| 11.94x | 0.85x | 0.11x | 0.28x | 2.73x | 5.64x | 4.25% | 95Cr | ||
| 27.18x | 7.32x | 1.12x | 0.97x | 13.34x | 21.15x | 1.34% | 80Cr | ||
| 14.33x | 1.93x | 1.18x | 0.69x | 8.41x | 13.57x | 0.36% | 70Cr | ||
| Average | 13.26x | 3.31x | 1.89x | 0.80x | 9.52x | 20.11x | 2.63% | 345.64Cr | |
| Weighted average by Cap. | 15.79x | 2.66x | 2.42x | 0.80x | 10.16x | 15.33x | 1.91% |
- Stock Market
- Stocks
- 4164 Stock
- Sector Nahdi Medical Company
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















